MLICM
NUVB icon

Metropolitan Life Insurance Company (MetLife)’s Nuvation Bio NUVB Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio NUVB Stock Details NUVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-5,276
Closed -$19.2K – 1416
2024
Q1 		$19.2K Buy
5,276
+1,338
+34% +$2.57K ﹤0.01% 1882
2023
Q4 		$5.95K Sell
3,938
-4,860
-55% -$6.25K ﹤0.01% 2271
2023
Q3 		$11.8K Buy
8,798
+1,842
+26% +$3.07K ﹤0.01% 2144
2023
Q2 		$12.5K Hold
6,956
– – ﹤0.01% 2179
2023
Q1 		$11.5K Sell
6,956
-569
-8% -$1.15K ﹤0.01% 2103
2022
Q4 		$14.4K Hold
7,525
– – ﹤0.01% 2150
2022
Q3 		$16.9K Hold
7,525
– – ﹤0.01% 2104
2022
Q2 		$24.4K Sell
7,525
-3,474
-32% -$15.2K ﹤0.01% 1945
2022
Q1 		$57.9K Sell
10,999
-31,743
-74% -$178K ﹤0.01% 1518
2021
Q4 		$363K Buy
42,742
+23,410
+121% +$215K ﹤0.01% 1624
2021
Q3 		$192K Buy
19,332
+6,321
+49% +$57.3K ﹤0.01% 2109
2021
Q2 		$121K Buy
+13,011
New +$148K ﹤0.01% 2494

Other funds holding NUVB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $661M AUM 299.97% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

Metropolitan Life Insurance Company (MetLife)'s NUVB Position: Q2 2024 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Nuvation Bio (NUVB) in Q2 2024, closing a stake of 5,276 shares — an estimated $19.2K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in NUVB in Q2 2021 and held it in 12 quarters. The position peaked at $363K in Q4 2021. 148 funds tracked by Wall St. Rank hold NUVB as of Q2 2024.

  • Metropolitan Life Insurance Company (MetLife) reported no remaining Nuvation Bio position as of Q2 2024 after selling out during the quarter.
  • Metropolitan Life Insurance Company (MetLife) sold 5,276 Nuvation Bio shares in Q2 2024, an estimated $19.2K.
  • Metropolitan Life Insurance Company (MetLife) first reported a position in Nuvation Bio in Q2 2021 and held it in 12 quarters.
  • Metropolitan Life Insurance Company (MetLife)'s Nuvation Bio position peaked at $363K in Q4 2021.
  • 148 funds tracked by Wall St. Rank held Nuvation Bio as of Q2 2024.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2024, filed 13 Aug 2024.